A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2017 Sep 18

PMID 28918037

Citations 22

Authors

Funan Liu

Zhenguo Cheng

Xiaodong Li

Yanshu Li

Hongyan Zhang

Jiabin Li

Furong Liu

Huimian Xu

Feng Li

Affiliations

Soon will be listed here.

Abstract

We, along with others, have shown previously that P21-activated kinase 1 (Pak1) plays a pivotal role in gastric cancer progression and metastasis. However, whether Pak1 controls gastric cancer metastasis by regulating microRNAs (miRNAs) has never been explored. Here, we report a novel mechanism of Pak1 in tumor metastasis. A detailed examination revealed that Pak1 interacts with and phosphorylates the serine 62 residue of ATF2 and then blocks its translocation into the nucleus. We also confirmed that ATF2 binds to the promoter of miR-132 and tightly regulates its transcription, thus explaining the regulatory mechanism of miR-132 by Pak1. miR-132 also significantly reduced cell adhesion, migration, and invasion of gastric cancer cells in vitro and significantly prevented tumor metastasis in vivo. miR-132 specifically inhibited hematogenous metastasis, but not lymph node or implantation metastases. In order to further delineate the effects of the Pak1/ATF2/miR-132 cascade on gastric cancer progression, we identified several targets of miR-132 using a bioinformatics TargetScan algorithm. Notably, miR-132 reduced the expression of CD44 and fibronectin1 (FN1), and such inhibition enabled lymphocytes to home in on gastric cancer cells and induce tumor apoptosis. Taken together, our studies establish a novel cell-signaling pathway and open new possibilities for therapeutic intervention of gastric cancer.

Citing Articles

The ATF2/miR-3913-5p/CREB5 axis is involved in the cell proliferation and metastasis of colorectal cancer.

Dai W, Hong L, Xiao W, Zhang L, Sha W, Yu Z Commun Biol. 2023; 6(1):1026.

PMID: 37816820 PMC: 10564889. DOI: 10.1038/s42003-023-05405-w.

mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the 3'-UTR-let-7i-5p-THBS1 axis.

Pan S, Zhu J, Liu P, Wei Q, Zhang S, An W Theranostics. 2023; 13(14):5130-5150.

PMID: 37771777 PMC: 10526670. DOI: 10.7150/thno.82492.

Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer.

Somanath P, Chernoff J, Cummings B, Prasad S, Homan H Cancers (Basel). 2023; 15(8).

PMID: 37190165 PMC: 10137274. DOI: 10.3390/cancers15082236.

The Characterization and Differential Analysis of mA Methylation in Hycole Rabbit Muscle and Adipose Tissue and Prediction of Regulatory Mechanism about Intramuscular Fat.

Luo G, Ai Y, Yu L, Wang S, Ren Z Animals (Basel). 2023; 13(3).

PMID: 36766336 PMC: 9913852. DOI: 10.3390/ani13030446.

p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.

Li X, Li F Cancers (Basel). 2022; 14(19).

PMID: 36230657 PMC: 9563254. DOI: 10.3390/cancers14194736.

References

Cheng Z, Liu F, Wang G, Li Y, Zhang H, Li F . miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal. 2014; 26(12):2667-73. DOI: 10.1016/j.cellsig.2014.08.012. View

Formosa A, Lena A, Markert E, Cortelli S, Miano R, Mauriello A . DNA methylation silences miR-132 in prostate cancer. Oncogene. 2012; 32(1):127-34. DOI: 10.1038/onc.2012.14. View

Cheng F, Su L, Yao C, Liu L, Shen J, Liu C . SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Lett. 2016; 375(2):274-283. DOI: 10.1016/j.canlet.2016.03.010. View

Yasuda M, Tanaka Y, Fujii K, Yasumoto K . CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int Immunol. 2001; 13(10):1309-19. DOI: 10.1093/intimm/13.10.1309. View

Shi Z, Wei Q, She J . MicroRNAs in gastric cancer metastasis. Crit Rev Eukaryot Gene Expr. 2014; 24(1):39-53. DOI: 10.1615/critreveukaryotgeneexpr.2014007896. View

Claps G, Cheli Y, Zhang T, Scortegagna M, Lau E, Kim H . A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. Cell Rep. 2016; 15(9):1884-92. PMC: 4889472. DOI: 10.1016/j.celrep.2016.04.072. View

Xu J, Liu H, Chen L, Wang S, Zhou L, Yun X . Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology. 2012; 143(1):199-212.e4. DOI: 10.1053/j.gastro.2012.03.053. View

Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean M, Validire P, Trautmann A . Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012; 122(3):899-910. PMC: 3287213. DOI: 10.1172/JCI45817. View

ONeill L . Boosting the brain's ability to block inflammation via microRNA-132. Immunity. 2010; 31(6):854-5. DOI: 10.1016/j.immuni.2009.11.004. View

10.

Wang J, Xu G, Shen F, Kang Y . miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol. 2014; 35(5):4859-65. DOI: 10.1007/s13277-014-1637-2. View

11.

Liu F, Li X, Wang C, Cai X, Du Z, Xu H . Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1. Int J Cancer. 2009; 125(11):2511-9. DOI: 10.1002/ijc.24588. View

12.

Zhang L, Huang D, Wang Q, Shen D, Wang Y, Chen B . MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway. Cardiovasc Drugs Ther. 2014; 28(4):303-11. DOI: 10.1007/s10557-014-6533-x. View

13.

Jasinski-Bergner S, Mandelboim O, Seliger B . The role of microRNAs in the control of innate immune response in cancer. J Natl Cancer Inst. 2014; 106(10). DOI: 10.1093/jnci/dju257. View

14.

Chou J, Shahi P, Werb Z . microRNA-mediated regulation of the tumor microenvironment. Cell Cycle. 2013; 12(20):3262-71. PMC: 3885637. DOI: 10.4161/cc.26087. View

15.

Gozdecka M, Breitwieser W . The roles of ATF2 (activating transcription factor 2) in tumorigenesis. Biochem Soc Trans. 2012; 40(1):230-4. DOI: 10.1042/BST20110630. View

16.

Kumar R, Sanawar R, Li X, Li F . Structure, biochemistry, and biology of PAK kinases. Gene. 2016; 605:20-31. PMC: 5250584. DOI: 10.1016/j.gene.2016.12.014. View

17.

Zhang Z, Chen W, Wu Y, Liang H, Zhang B . MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochem Biophys Res Commun. 2014; 454(1):109-14. DOI: 10.1016/j.bbrc.2014.10.049. View

18.

Van Obberghen-Schilling E, Tucker R, Saupe F, Gasser I, Cseh B, Orend G . Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol. 2011; 55(4-5):511-25. DOI: 10.1387/ijdb.103243eo. View

19.

Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber E . Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci U S A. 2009; 106(26):10746-51. PMC: 2705554. DOI: 10.1073/pnas.0811817106. View

20.

Adam L, Vadlamudi R, Kondapaka S, Chernoff J, Mendelsohn J, Kumar R . Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J Biol Chem. 1998; 273(43):28238-46. DOI: 10.1074/jbc.273.43.28238. View